Tag: decentralized clinical trials

CRO Readiness for Decentralized Clinical Trial Audits

August 28, 2025

CRO Readiness for Decentralized Clinical Trial Audits Ensuring CRO Readiness for Decentralized Clinical Trial Audits Introduction: Decentralized Clinical Trials and CRO Responsibilities Decentralized Clinical Trials (DCTs) represent a transformative model for clinical research, enabling patient participation through telemedicine, remote data capture, home visits, and digital health technologies. Regulatory authorities, including FDA, EMA, and MHRA, have…

CRO Audits, CAPA, and Deviation Management, Inspection Readiness for CROs

Decentralized Clinical Trials in Rare Diseases: Opportunities and Risks

August 23, 2025

digi

Decentralized Clinical Trials in Rare Diseases: Opportunities and Risks Harnessing Decentralized Clinical Trials to Improve Access in Rare Disease Research The Rationale for Decentralization in Rare Disease Trials Rare disease trials face one central challenge: patient scarcity scattered across vast geographies. Traditional site-based clinical trials often fail to recruit sufficient participants due to travel limitations,…

Rare and Orphan Disease Trials, Trial Design & Methodology

Digital Biomarker Validation in Rare Disease Research

August 22, 2025

digi

Digital Biomarker Validation in Rare Disease Research Validating Digital Biomarkers in Rare Disease Clinical Research The Role of Digital Biomarkers in Rare Disease Studies Digital biomarkers—objective, quantifiable measures of physiological and behavioral data collected through digital devices—are revolutionizing how rare disease trials generate endpoints. Examples include gait analysis from wearable accelerometers, speech pattern changes detected…

Data & Technology, Rare and Orphan Disease Trials

Integrating Wearable Device Data into Clinical EDC Systems for Trials

August 20, 2025

digi

Integrating Wearable Device Data into Clinical EDC Systems for Trials How to Seamlessly Integrate Wearable Data into EDC Systems Introduction to Wearables and EDC Integration Wearable devices are revolutionizing clinical trials by enabling real-time, continuous data capture from participants. These include smartwatches, ECG patches, biosensors, and fitness trackers. However, capturing this data is only half…

AI, Big Data, and Technology in Clinical Trials, Wearable Devices and Sensors

Integrating Wearable Devices in Rare Disease Clinical Trials

August 20, 2025

digi

Integrating Wearable Devices in Rare Disease Clinical Trials How Wearable Technologies are Revolutionizing Rare Disease Clinical Trials The Role of Wearables in Rare Disease Research Rare disease clinical trials face challenges such as small populations, geographically dispersed patients, and the need for long-term monitoring. Wearable devices—ranging from wristbands and accelerometers to advanced biosensors—are increasingly being…

Data & Technology, Rare and Orphan Disease Trials

Types of Wearables Used in Modern Clinical Trials

August 18, 2025

digi

Types of Wearables Used in Modern Clinical Trials Wearable Devices Transforming Modern Clinical Trials Introduction: A Paradigm Shift in Clinical Trial Data Collection Wearable technology is no longer a futuristic concept—it’s a present-day enabler of transformation in clinical trials. The convergence of biosensors, artificial intelligence, and miniaturized electronics has led to an explosion of wearable…

AI, Big Data, and Technology in Clinical Trials, Wearable Devices and Sensors

Decentralized Clinical Trials: Lessons from Recent Implementations

August 17, 2025

digi

Decentralized Clinical Trials: Lessons from Recent Implementations Decentralized Clinical Trials: Implementation Lessons and Regulatory Oversight Introduction: The Rise of Decentralized Clinical Trials Decentralized Clinical Trials (DCTs) leverage digital technologies, telemedicine, and direct-to-patient logistics to reduce reliance on traditional site-based models. For US sponsors, the FDA encourages decentralized elements where appropriate, particularly under the 2020 FDA…

Clinical Trial Operations & Compliance, Clinical Trial Phases & Design

Policy Reforms in Global Rare Disease Regulation

August 7, 2025

digi

Policy Reforms in Global Rare Disease Regulation How Global Policy Reforms Are Shaping the Future of Rare Disease Regulation The Need for Regulatory Reform in Rare Disease Drug Development Rare diseases, often called orphan conditions, affect over 300 million people globally—yet less than 5% have an approved treatment. Traditional drug development frameworks often fall short…

Rare and Orphan Disease Trials, Regulatory Incentives

Ensuring Data Completeness in Decentralized Trials

July 29, 2025

digi

Ensuring Data Completeness in Decentralized Trials Ensuring Data Completeness in Decentralized Clinical Trials (DCTs) Why Data Completeness Matters in Decentralized Clinical Trials As decentralized clinical trials (DCTs) become more mainstream, ensuring complete data collection has become a critical regulatory and operational challenge. With trial components distributed across digital platforms, home visits, wearable devices, and telehealth…

Complete, Consistent, Enduring, and Available (ALCOA+), Data Integrity and ALCOA+ Principles

Using Mobile Apps to Improve Trial Retention in Clinical Studies

June 14, 2025

digi

Using Mobile Apps to Improve Trial Retention in Clinical Studies How Mobile Apps Are Improving Trial Retention in Clinical Studies In today’s digitized healthcare landscape, mobile technology is transforming clinical trials. One of the most powerful tools now available to researchers is the mobile app—designed to streamline communication, data capture, and engagement. Beyond convenience, mobile…

Patient Recruitment and Retention, Retention Strategies